# Molecular signaling mechanisms controlling Cryptosporidium proliferation and development

> **NIH NIH R01** · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · 2024 · $384,166

## Abstract

Project Abstract
Cryptosporidium is a leading cause of diarrheal disease (cryptosporidiosis) and death among young children
living in resource-poor settings. In the US, Cryptosporidium is the major cause of waterborne outbreaks linked
to recreational water use. Currently, there is no fully effective drug and no vaccine to treat or prevent
cryptosporidiosis. The only available US FDA approved drug, nitazoxanide has no proven efficacy in young
children with weak immune status and immunocompromised individuals. Therefore, there is an urgent need to
develop new drugs and vaccine to reduce the burden of cryptosporidiosis. Progress in anti-cryptosporidial drug
and vaccine development has been hampered due to our limited understanding of parasite biology. The
underlying reasons for this slow progress have been the unavailability of a robust method to continuously
propagate Cryptosporidium, and the absence of molecular genetics to manipulate the parasite genome. We have
overcome these hurdles by developing a powerful technology to manipulate the Cryptosporidium genome and
propagate these genetically modified parasites in an immunocompromised mouse model system. The key
advantage of this genetic system is that the entire life cycle of Cryptosporidium (both asexual and sexual stages)
is completed in the mouse intestine, allowing us to unravel parasite biology (Vinayak et al 2015, Nature 523:477).
We lack an understanding of the molecular signaling mechanisms that control development of parasite stages
for successful completion of the complex life cycle. Signaling pathway components such as the plant-like
calcium-dependent protein kinases (CDPKs) have emerged as attractive drug targets in Cryptosporidium and
related parasites, due to the absence of their homologues in human host. Taking advantage of our genetic
system, we have demonstrated the efficacy of selective bumped kinase inhibitors against calcium-dependent
protein kinase-1 (CDPK1), thus indicating a critical role of this signaling kinase in C. parvum. Utilizing the
conditional protein degradation system recently developed in our laboratory, we have demonstrated the essential
role of CDPK1 in asexual proliferation and parasite survival. Moreover, we have compelling preliminary evidence
that sheds light on the role of two signaling kinases in sexual developmental stages. The goal of this project is
to elucidate the mechanistic role of these signaling proteins in regulating development of asexual and sexual
stages in C. parvum required for parasite proliferation and transmission. Elucidation of these mechanisms will
provide novel insights into the fundamental biology of Cryptosporidium, and open new avenues for development
of effective therapies.

## Key facts

- **NIH application ID:** 10765645
- **Project number:** 5R01AI150961-04
- **Recipient organization:** UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
- **Principal Investigator:** Sumiti Vinayak Alam
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $384,166
- **Award type:** 5
- **Project period:** 2021-02-01 → 2026-01-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10765645

## Citation

> US National Institutes of Health, RePORTER application 10765645, Molecular signaling mechanisms controlling Cryptosporidium proliferation and development (5R01AI150961-04). Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/grant/nih/10765645. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*